Back to search
Vision Loss
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vision Loss trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Vision Loss trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
The purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retin…
Society has become increasingly digital, and many everyday services have been replaced by digital self-service solutions. This puts greater demands on our visio…
This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observati…
The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood canc…
Optic neuritis is an important cause of acute or subacute visual loss. In clinical practice, optic neuritis must often be distinguished from other optic neuropa…
The goal of this observational study is to to compare dental caries impacts and experience among visually impaired and sighted children. The main question it ai…
Damage to visual cortex on one side of the brain frequently produces a profound and permanent blindness in contralesional space (hemianopia), a debilitating con…